| NCT ID | NCT06345976 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild |
| Condition | Albinism, Ocular |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-10-01 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Albinism is a genetic and hereditary anomaly that affects pigmentation. This pathology is characterized by a deficit in melanin production. In humans, the clinical diagnosis of albinism is based on a number of factors, including : * In the integumentary region: fair skin tone, with white hair, eyelashes and eyebrows. * Ophthalmological: reduced visual acuity, photophobia, nystagmus, transilluminated blue irises, hypopigmentation of the retina at the back of the eye with fovea plana. As treatment options begin to emerge for certain albinism-induced anomalies (including, for example, the depigmentation that causes photophobia), it is desirable to understand what these patients' complaints are, and to gather their views on the emergence of treatments targeting just one of their complaints, namely glare.
Eligibility Criteria
Inclusion Criteria: * All patients with albinism * Patients \> 18 years of age * Non-opposition to study participation Exclusion Criteria: No diagnosis according to Kruijt et al. criteria Impossibility (visual, technological) of completing questionnaire
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06345976 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Albinism, Ocular. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06345976 currently recruiting?
Yes, NCT06345976 is actively recruiting participants. Contact the research team at ayavchitz@for.paris for enrollment information.
Where is the NCT06345976 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06345976 clinical trial?
NCT06345976 is sponsored by Fondation Ophtalmologique Adolphe de Rothschild. The trial plans to enroll 50 participants.